ABVC Non Current Liabilities Total from 2010 to 2024
| ABVC Stock | USD 1.08 0.07 6.09% |
Non Current Liabilities Total | First Reported 2003-06-30 | Previous Quarter 2.2 M | Current Value 429.1 K | Quarterly Volatility 1.3 M |
Check ABVC Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ABVC main balance sheet or income statement drivers, such as Interest Expense of 2.6 M, Selling General Administrative of 5 M or Total Revenue of 157.4 K, as well as many exotic indicators such as Price To Sales Ratio of 31.34, Dividend Yield of 0.0 or PTB Ratio of 0.54. ABVC financial statements analysis is a perfect complement when working with ABVC Biopharma Valuation or Volatility modules.
ABVC | Non Current Liabilities Total |
Latest ABVC Biopharma's Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of ABVC Biopharma over the last few years. It is ABVC Biopharma's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ABVC Biopharma's overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
| Timeline |
ABVC Non Current Liabilities Total Regression Statistics
| Arithmetic Mean | 833,596 | |
| Geometric Mean | 85,343 | |
| Coefficient Of Variation | 136.30 | |
| Mean Deviation | 862,701 | |
| Median | 407,680 | |
| Standard Deviation | 1,136,163 | |
| Sample Variance | 1.3T | |
| Range | 4.1M | |
| R-Value | 0.05 | |
| Mean Square Error | 1.4T | |
| R-Squared | 0 | |
| Significance | 0.87 | |
| Slope | 11,757 | |
| Total Sum of Squares | 18.1T |
ABVC Non Current Liabilities Total History
About ABVC Biopharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ABVC Biopharma income statement, its balance sheet, and the statement of cash flows. ABVC Biopharma investors use historical funamental indicators, such as ABVC Biopharma's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although ABVC Biopharma investors may use each financial statement separately, they are all related. The changes in ABVC Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ABVC Biopharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ABVC Biopharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ABVC Biopharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Total | 429.1 K | 407.7 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ABVC Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ABVC Biopharma's short interest history, or implied volatility extrapolated from ABVC Biopharma options trading.
Pair Trading with ABVC Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABVC Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against ABVC Stock
| 0.52 | LLY | Eli Lilly Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to ABVC Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABVC Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABVC Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABVC Biopharma to buy it.
The correlation of ABVC Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABVC Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABVC Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABVC Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of ABVC Biopharma Correlation against competitors. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is ABVC Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.43) | Revenue Per Share 0.035 | Quarterly Revenue Growth (1.00) | Return On Assets (0.43) | Return On Equity (1.92) |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.